SavedAdd your journal

Journals / DAHUDER Medical Journal / 2023 / Cilt: 3 - Sayı: 1

The relationship between monocyte/HDL cholesterol ratio and chronic kidney disease stages, single center study

İhsan SOLMAZ
Ömer Faruk ALAKUŞ
Yusuf YAKUT
Yunus TEKİN
Sedrettin KOYUN
Eşref ARAÇ
Pages
9–12
Publication Date
2023-01-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Kruskal-Wallis and post hoc Tukey HSD tests were used for statistics. p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Chronic kidney disease (CKD) is an increasing public health problem.
📊
Key Findings & Data:In this study, it was aimed to investigate the relationship between stages and MHR in patients with stage 3A, stage 3B and stage 4 CKD.
💡
Conclusion & Impact:Kruskal-Wallis and post hoc Tukey HSD tests were used for statistics. p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Monocyte-to-HDL ratio · Chronic kidney disease · Stage

Abstract

Objectives: Chronic kidney disease (CKD) is an increasing public health problem. It is very important to know the definition of CKD, its risk factors and to predict the progression of its stages. Recently, the monocyte/HDL ratio (MHR) has been thought to be a new marker of inflammation and oxidative stress. In this study, it was aimed to investigate the relationship between stages and MHR in patients with stage 3A, stage 3B and stage 4 CKD. Methods: A total of 632 patients with CKD, aged 18 years and older, with stage 3A, stage 3B and stage 4 (eGFR) according to CKD stage were included in our study. Our study is retrospective and the data of the patients were obtained from the hospital system. Kruskal-Wallis and post hoc Tukey HSD tests were used for statistics. p

🔖

Cite This Article

SOLMAZ, İ., ALAKUŞ, Ö. F., YAKUT, Y., TEKİN, Y., KOYUN, S., ARAÇ, E. (2023). The relationship between monocyte/HDL cholesterol ratio and chronic kidney disease stages, single center study. DAHUDER Medical Journal, Cilt: 3 - Sayı: 1, 9–12. https://ajindex.com/articles/878772

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Hebert LA, ve ark. Renoprotection: One or many therapies? Kidney Int 59:1211-1226, 2001.
  2. Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of HDL. Circ Res. 2004;95:764–772.
  3. Negi G, Kumar A, Joshi RP, et al. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem and Biophys Res Commun. 2011;408:1–5.
  4. You S, Zhong C, Zheng D, Xu J, Zhang X, Liu H et al. Monocyte to HDL cholesterol ratio is associated with discharge and 3-month outcome in patients with acute intracerebral hemorrhage. J Neurol Sci 2017; 372: 157-61.
  5. Karataş MB, Çanga Y, Özcan KS, Ipek G, Güngör B, Onuk T et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med 2016; 34(2): 240-4.
  6. Canpolat U, Aytemir K, Yorgun H, Şahiner L, Kaya EB, Çay S et al. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace 2015; 17(12): 1807-15.
  7. Canpolat U, Çetin EH, Cetin S, Aydin S, Akboga MK, Yayla C et al. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation. Clin Appl Thromb Hemost 2016; 22(5): 476-82.
  8. Balta S, Celik T, Ozturk C, Kaya MG, Aparci M, Yildirim AO et al. The relation between monocyte to HDL ratio and noreflow phenomenon in the patients with acute ST-segment elevation myocardial infarction. Am J Emerg Med 2016; 34(8): 1542-7.
  9. Ancuta P, Wang J, Gabuzda D. CD16 + monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J Leukoc Biol 2006; 80(5): 1156-64.
  10. Hessler JR, Robertson AL, Chisolm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979; 32(3): 213-29.
  11. Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC. Protective effect of high density lipoprotein on endothelium dependent vasodilatation. Int J Cardiol 2000; 73(3): 231-6.
  12. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990; 1044(2): 275–83.
  13. Sözel Hasan, Avşar Esin, Alemdar Mustafa Serkan, Aydemir Mustafa Diyabetik süreçtemonosit/HDL kolesterol ve nötrofil/HDL kolesterol oranları. İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi, 2022;26(1):19 – 29 Solmaz,